23 results found
Searchresult 1 - 10 of 23. You filter by “Hospital care”.
-
Room for collaborations as part of ‘the Right Care in the Right Place’
Many forms of collaborations are allowed. However, collaborations can also go too far. That is why ACM has provided more clarity in its ‘Policy Rule on the Right Care in the Right Place’.
-
Health insurers and hospitals leave full potential of collective procurement of prescription drugs untapped
Hospitals and health insurers are not yet taking full advantage of the potential benefits that their collaborations in drug procurement are able to offer, according to the evaluation of the ‘Guidelines on collective procurement of prescription drugs’.
-
ACM: a broad-based effort is needed for long-term competition in anti-rheumatic prescription drugs
The expiration of patents and the market entry of competing drugs have led to drops in the net purchasing prices of TNF-alpha inhibitors. In order to guarantee their affordability in the future, a broad-based effort is needed.
-
Sector inquiry into TNF alpha inhibitors
ACM conducted a sector inquiry into TNF alpha inhibitors. The expiration of patents has led to lower prices. To guarantee their affordability in the future, competitors must be able to gain a solid position on the Dutch market.
-
When merging, health care providers must identify health care more accurately
From January 1, 2019, hospitals and independent treatment centers that wish to merge have to provide ACM more detailed information for the analysis of product markets.
-
ACM procedure regarding analyses of product markets in hospital care
From now on, ACM will analyze product markets in hospital care at the patient group level. Market participants that wish to merger must analyze their merger’s effects at that level.
-
Detailed explanation of ACM procedure regarding analyses of product market in hospital care
From now on, ACM will analyze product markets in hospital care at the patient group level. A DTC is designated as basic care if at least 20 general hospitals offer it. ACM explains its choices in this paper.
-
Product market definition in hospital care in the Netherlands
ACM has commissioned a research into the definition of product markets in the hospital care and what proportion of that care can be defined as complex care.
-
ACM clears merger between Bergman Clinics and NL Healthcare Clinics
Health care providers Bergman Clinics and NL Healthcare Clinics are allowed to merge. The merger will not affect consumer options. Insurers continue to have health care options at the best possible price-quality ratio.
-
Explanatory notes: Intensified attention for anticompetitive risks of hospital mergers
ACM has, based on recent studies, intensified its attention for anticompetitive risks of hospital mergers.